Patient Guide: Multiple-Dose, Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY3303560 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 3 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03019536
Status: COMPLETED_NEXT_PHASE_UPCOMING
Condition: Mild Cognitive Impairment Due to Alzheimer's Disease, Mild to Moderate Alzheimer's Disease
Phase: Phase I

Find a Study Location Near You

This study is available at 3 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • ,
  • ,
  • ,

Loading interactive enrollment tools...

The full interactive experience will load momentarily